Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: This study aimed to evaluate the effectiveness of fractional microneedle radio frequency (FMR) for treating erythematous acne scars in Asian patients living in the tropical zone.

Introduction: Erythematous acne scars pose a common and challenging issue for dermatologists in Asian populations. While the 595-nm Pulsed Dye Laser (PDL) has demonstrated efficacy in treating red lesions, its high cost and risk of hypopigmentation in darker Asian skin can hinder treatment. Fractional microneedle radiofrequency (FMR) has emerged as a promising option due to its ability to modulate inflammatory and vascular components in erythematous acne scars. However, there is currently limited data on the efficacy and safety of FMR for erythematous acne scars in Asian populations living in tropical zone.

Materials / method: This study enrolled 30 Asian patients living in the tropical zone with erythematous acne scars. All patients underwent four sessions of FMR treatment at four-week intervals. Scar severity was evaluated using the Global Acne Scarring Scale (GASS) before and three months after the last treatment session. Patient satisfaction was assessed using the Patient Scar Assessment Scale (PSAS).

Results: The mean GASS score decreased significantly from the average score of 4.2 ± 0.8 before treatment to 2.8 ± 0.9 at three months after the last treatment session (p < 0.001). The mean PSAS score also improved significantly from an average of 7.8 ± 1.1 before treatment to 4.3 ± 1.4 at three months after the last treatment session. No significant adverse events were reported.

Conclusion: FMR offers a safe and effective alternative to the 595-nm pulsed dye laser for treating erythematous acne scars in Asian patients residing in tropical regions. This study demonstrates that FMR can significantly improve scar severity and patient satisfaction. Further studies with larger sample sizes and longer follow-up periods are warranted to confirm these findings.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: This presentation serves to present our study investigating local alterations in hypertrophic scars. Attendees shall understand the differences between pathologic and non-pathologic scars as well as get insight into currently known scientific pathways of scar pathology.

Introduction: One of the long-term complications after every surgical procedure is the occurrence of hypertrophic scars. Depending on the available literature, they form in 30 to 70% of cases. Especially after elective aesthetic procedures these unwanted and disturbing scars present a major psychological and physical burden. Treatment modalities lack evidence not last because of the lack of standardized scar models.

Materials / method: Twenty-two standardized burn and 22 full-thickness skin wounds were placed on the backs of 6 Duroc pigs, whereas half of both had a prolonged inflammation with resiquimod induced. A modified Vancouver Scar Scale, hyperspectral photography and qPCR, and histology from biopsies were performed at defined time points to examine the different processes in the resulting wounds and scars.

Results: Native burn wounds as well as resiquimod-induced full-thickness and burn wounds resulted in more hypertrophic scars than full-thickness wounds. These three wound types also showed relative hypoxia compared with uninduced full-thickness wounds in hyperspectral imaging and increased genetic expression of hypoxia marker HIF1a. The highest number of inflammatory cells was detected in resiquimod-induced full-thickness wounds with histologic features of hypertrophic scars in burn and resiquimod-induced wounds.

Conclusion: According to our experiments, the use of resiquimod is suitable for provoking an earlier-occurring hypertrophic scar. The results suggest that hypoxia is the driving factor in promoting inflammation and thus the appearance of hypertrophic scars. This model allows for the generation of solid hypertrophic scars that can be used to further investigate and define working points in scar treatment, one of which should be the early oxygenation of wounds.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability